TXMD יחס מהיר TherapeuticsMD Inc

TherapeuticsMD, Inc. (TXMD) is expanding its presence in the US market by licensing its product rights. Stable sales are driven by patent-protected hormonal treatments that maintain strong consumer trust among women. This price trend, featuring the 2.80 indicator, illustrates the stock dynamics of a company that has shifted toward a royalty-based model and delegated FDA oversight to its counterparties.

This indicator assesses the ability of TherapeuticsMD, Inc. (TXMD) to instantaneously settle short-term obligations using only cash and accounts receivable, excluding inventory. The analysis of the quick ratio on GURU.Markets reflects the actual financial reserve of TherapeuticsMD, Inc., confirming that its status as an authoritative developer of women's health pharmaceuticals is supported by factual solvency and capital stability.